Quinaprilat structure
|
Common Name | Quinaprilat | ||
---|---|---|---|---|
CAS Number | 1435786-09-6 | Molecular Weight | 456.53100 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C25H32N2O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of QuinaprilatQuinaprilat hydrate is a non-mercapto Angiotensin Converting Enzyme (ACE) inhibitor, the active metabolite of Quinapril. Quinaprilat hydrate specifically blocks the conversion of angiotensin I to the vasoconstrictor angiotensin II and inhibits the degradation of bradykinin. Quinaprilat hydrate acts as anti-hypertensive agent and vasodilator[1][2]. |
Name | (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid,hydrate |
---|---|
Synonym | More Synonyms |
Description | Quinaprilat hydrate is a non-mercapto Angiotensin Converting Enzyme (ACE) inhibitor, the active metabolite of Quinapril. Quinaprilat hydrate specifically blocks the conversion of angiotensin I to the vasoconstrictor angiotensin II and inhibits the degradation of bradykinin. Quinaprilat hydrate acts as anti-hypertensive agent and vasodilator[1][2]. |
---|---|
Related Catalog | |
In Vitro | Quinaprilat hydrate (5 μM) mediates the interaction of organic anion transporter 3 (hOAT3) which can promote renal active secretion of quinapril that increases uptake of quinaprilat to 25-fold in HEK293 cells and hOAT3 affinity Km for quinaprilat is 13.4 μM[1]. Quinaprilat hydrate (100 nM, 20 min) can inhibit the activity of protein kinase C (PKC) by activing the B1 receptor resulting in the release of NO in human lung microvascular endothelial (HLMVE) cells[2]. |
References |
Molecular Formula | C25H32N2O6 |
---|---|
Molecular Weight | 456.53100 |
Exact Mass | 456.22600 |
PSA | 105.17000 |
LogP | 2.83160 |
Quinapril diacid [MI] |
3-Isoquinolinecarboxylic acid,2-(2-((1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-,(3S-(2(R*(R*)),3R*))-,monohydrate |
Quinapril diacid |
Quinaprilat hydrate [WHO-DD] |